TOBINintel · Condition
Asthma & Allergic Airway Disease
Airway inflammation is mapped against indoor and outdoor exposures, immune phenotype, microbial ecology and nutrient status, with guideline therapy always in the foreground.
Key points
- Respiratory virome and airway bacteriome are assessed as exacerbation triggers; colonization is distinguished from active infection before antimicrobials are considered.
- Test to discuss: Spirometry with reversibility
- Test to discuss: FeNO and blood eosinophils
- Test to discuss: Specific IgE or component testing
- Test to discuss: Home dampness and exposure history
- Allergen and irritant reduction at home
- Fragrance and aerosol avoidance
- Air filtration during high-pollution days
- Vaccination per guideline
Root-cause chain
T · Established causal · Allergen challenge and pollution exposure studies consistently show eosinophilic airway inflammation and exacerbation risk.
I · Established causal · Mediator release drives smooth-muscle constriction, edema and mucus production.
I · Observational association · Dampness indices associate with asthma symptoms; specific causal agents are rarely isolated.
N · Randomized evidence · Meta-analyses show reduced exacerbations with repletion in deficient patients.
Protocols by lane
Evidence grade + regulatory statusGuideline-preferred therapy reducing exacerbations across severities.
Status: FDA-approved · Cautions: Review technique; oral candidiasis and dysphonia with poor rinse habits.
Reduces trigger load in dampness and allergen-heavy homes.
Status: Lifestyle · Cautions: Remediation must not delay controller therapy.
Reduces exacerbation rate in deficiency.
Status: Supplement · Cautions: Dose to measured level; not a controller substitute.
Improves symptom scores and quality of life as an adjunct.
Status: Lifestyle · Cautions: Adjunct only; does not alter airway inflammation.
Traditional symptom relief with little controlled evidence.
Status: Lifestyle · Cautions: Burn risk; essential-oil aerosols can trigger bronchospasm.
No adequate evidence of benefit.
Status: Investigational · Cautions: Must never replace controller or rescue therapy.
Monitoring
- Symptom control score at each visit
- Inhaler technique and adherence
- Exacerbation and steroid-burst count
Go deeper
iDetection of an exposure does not establish that it caused a disease. This platform separates exposure, association, plausible mechanism, clinical evidence and demonstrated causation.